Representative before the EPO

Company dna mintz levin cohn ferris glovsky and popeo llp
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Company dna cooley uk llp
no operation time available
2 offices
active in Legal Services

We have observed 24 EP applications Jacqueline Frances Moore has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11807478

METHOD AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES

IPC classification:
A61K 9/00, A61K 9/20, A61K 9/22, A61K 31/7012, A61K 47/38, A61P 21/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP12725813

PROTEIN HAVING NUCLEASE ACTIVITY, FUSION PROTEINS AND USES THEREOF

IPC classification:
A01K 67/027, C07K 14/415, C12N 15/62, C12N 15/82, C12N 15/85
Applicant:
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12832060

COMPOSITIONS OF JASMONATE COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 9/14, A61K 9/16, A61K 31/122, A61K 47/30, A61P 29/00, A61P 35/00
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12843460

SIALIC ACID ANALOGS

IPC classification:
A61K 31/7008, C07H 5/04, C07H 7/02
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12846033

PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES

IPC classification:
C07K 14/00, G01N 33/53, G01N 33/543
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12852350

SIGNAL AMPLIFICATION IN LATERAL FLOW AND RELATED IMMUNOASSAYS

IPC classification:
G01N 33/53, G01N 33/543
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13739040

METHODS AND FORMULATIONS FOR TREATING SIALIC ACID DEFICIENCIES

IPC classification:
A61K 9/20, A61K 9/22, A61K 31/16, A61K 31/195, A61K 31/196, A61K 31/27
Agent:
Andrew Jonathan Wills, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP12826427

FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

IPC classification:
A61K 9/00, A61K 38/17, A61K 38/22, A61K 38/26, A61K 38/28, A61M 31/00
Agent:
Robert John Stephen, Olswang LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13710253

IDENTIFICATION OF CHANNELRHODOPSIN-2 (CHOP2) MUTATIONS AND METHODS OF USE

IPC classification:
C07K 14/705
Applicant:
Wayne State University
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13764490

GUERBET ALCOHOLS AND METHODS FOR PREPARING AND USING SAME

IPC classification:
C07C 29/136, C07C 31/125, C07C 45/40, C07C 47/21
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13712057

FLUORINATED BENZOFURAN DERIVATIVES

IPC classification:
A61K 31/343, A61P 9/00, C07D 307/80
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13758533

USE OF THYMOSIN ALPHA FOR TREATMENT OF PURULENT RHINOSINUSITIS

IPC classification:
A61K 38/17, A61K 38/22, A61P 11/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13784431

FLUORINATED 2-AMINO-4-(BENZYLAMINO)PHENYLCARBAMATE DERIVATIVES

IPC classification:
A61B 8/13, A61K 31/27, A61K 31/44, A61P 25/08, C07C 271/28, C07D 213/75
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13722971

CARBAZOLE-CONTAINING SULFONAMIDES AS CRYPTOCHROME MODULATORS

IPC classification:
A61K 31/403, A61P 3/00, A61P 25/00, C07D 209/86, C07D 209/88, C07D 401/06, C07D 401/12, C07D 403/06, C07D 403/12, C07D 405/12, C07D 405/14, C07D 409/12, C07D 413/12, C07D 417/06, C07D 493/08
Agent:
Lionel Paul Clarke, Gill Jennings & Every LLP
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13820043

OZONOLYSIS OPERATIONS FOR GENERATION OF REDUCED AND/OR OXIDIZED PRODUCT STREAMS

IPC classification:
C07C 45/40, C07C 47/02, C07C 51/34, C07C 55/18
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13760222

N-(3-FLUOROBENZYL)-2-(5-(4-MORPHOLINOPHENYL)PYRIDIN-2-YL) ACETAMIDE AS PROTEIN!TYROSINE KINASE MODULATORS

IPC classification:
A61K 31/444, A61P 35/00, A61P 37/00, C07D 213/56
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION IN PROGRESS
EP13837402

METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF

IPC classification:
A61K 31/50, A61P 3/00, A61P 9/00, C07D 237/16
Applicant:
F. Hoffmann-La Roche Ltd.
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13802822

TREATMENT OF PULMONARY DISEASE

IPC classification:
A61K 31/575, A61P 11/00, A61P 11/06, A61P 11/08, A61P 35/00
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Agent:
Multiple attorneys, Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP14749249

FLUORINATED INTEGRIN ANTAGONISTS

IPC classification:
A61K 31/4375, A61P 3/10, C07D 471/04
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
The patent has been granted
EP14767480

MODULATION OF PLANT IMMUNE SYSTEM FUNCTION

IPC classification:
A01N 65/00, C07K 16/00
Agent:
Sarah Elizabeth Roques, J A Kemp
Agent:
Jacqueline Gail Victoria Evans, Marches Intellectual Property Ltd
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14724204

OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE

IPC classification:
A61K 9/00, A61K 31/425, A61K 47/40, A61L 15/42, A61L 15/56
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP14791444

METHODS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4406
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Status:
EXAMINATION REQUESTED
EP15175719

PRECURSOR OF PROPIONYL COENZYME A FOR USE IN THE TREATMENT OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES

IPC classification:
A61K 31/225
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Agent:
Cabinet Plasseraud
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
EXAMINATION REQUESTED
EP16182023

SINUS DELIVERY OF SUSTAINED RELEASE THERAPEUTICS

IPC classification:
A61F 13/00, A61K 9/00, A61K 47/34
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature